Retraction: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells

Retraction of ‘MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells’ by Guimin Chen et al., RSC Adv., 2019, 9, 21139–21146, DOI: 10.1039/C8RA10224D.

Detalles Bibliográficos
Autor principal: Fisher, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694687/
https://www.ncbi.nlm.nih.gov/pubmed/35427004
http://dx.doi.org/10.1039/d1ra90049h

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694687/
https://www.ncbi.nlm.nih.gov/pubmed/35427004
http://dx.doi.org/10.1039/d1ra90049h

Ejemplares similares